End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
98.1 TWD | +3.26% | +6.86% | +137.53% |
May. 13 | Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Easywell Biomedicals, Inc. announced a financing transaction | CI |
Sales 2022 | 179M 5.52M | Sales 2023 | 272M 8.38M | Capitalization | 4.79B 148M |
---|---|---|---|---|---|
Net income 2022 | -161M -4.96M | Net income 2023 | -145M -4.47M | EV / Sales 2022 | 10.3 x |
Net Debt 2022 | 10.42M 321K | Net Debt 2023 | 38.31M 1.18M | EV / Sales 2023 | 17.8 x |
P/E ratio 2022 |
-11.4
x | P/E ratio 2023 |
-32.6
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 43.58% |
1 day | +3.26% | ||
1 week | +6.86% | ||
Current month | +6.86% | ||
1 month | +25.77% | ||
3 months | +60.82% | ||
6 months | +143.12% | ||
Current year | +137.53% |
Managers | Title | Age | Since |
---|---|---|---|
Ai Ping Lee
CEO | Chief Executive Officer | - | 14-08-31 |
Hsueh Chun Wu
DFI | Director of Finance/CFO | - | - |
Howard Lee
BRD | Director/Board Member | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jy Gang Ger
BRD | Director/Board Member | - | 16-06-22 |
Chih Cheng Chang
BRD | Director/Board Member | - | 13-10-24 |
Han Fei Lin
CHM | Chairman | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 98.1 | +3.26% | 411,965 |
24-06-06 | 95 | -3.65% | 428,203 |
24-06-05 | 98.6 | +2.71% | 408,896 |
24-06-04 | 96 | +3.23% | 568,984 |
24-06-03 | 93 | +1.31% | 272,456 |
End-of-day quote Taipei Exchange, June 06, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+137.53% | 369M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- 1799 Stock